• Helen Triantafyllidi, Dimitrios Iordanidis, Aikaterini Mpahara, Maria Mademli, Dionyssia Birmpa, Stylianos Argentos, Dimitrios Benas, Paraskevi Trivilou, Konstantinos Anagnostopoulos, and Eckhard Mayer.
• 2nd Department of Cardiology, Medical School, ATTIKON Hospital, University of Athens, 12462 Athens, Greece.
• Medicina (Kaunas). 2021 Sep 20; 57 (9).

AbstractIn this article, we present the case of a 38-year-old female who suffered from serious respiratory distress. After an extensive pulmonary artery imaging diagnostic work-up (CTPA, MRA and PET), we were unable to differentiate between chronic thromboembolic pulmonary hypertension (CTEPH) vs. pulmonary artery sarcoma (PAS) due to extensive filling defects and extraluminal findings. Although surgery was postponed for nine months due to the COVID-19 pandemic, CTEPH diagnosis, due to a high-thrombus burden, was finally confirmed after pulmonary endarterectomy (PEA). Conclusively, imaging findings of rare cases of CTEPH might mimic PAS and the surgical removal of the lesion are both needed for a final diagnosis. What is Already Known about This Topic? Pulmonary artery sarcoma (PAS) is a rare but aggressive malignancy, which originates from the intimal layer of the pulmonary artery (PA); Chronic thromboembolic pulmonary hypertension (CTEPH) is based on chronic, organized flow-limiting thrombi inside PA circulation and subsequent pulmonary hypertension. What Does This Study Contribute? Since radiological findings of CTEPH cases might rarely mimic PAS, pulmonary artery endarterectomy and subsequent histopathologic study are needed for a final diagnosis.

24 keywords...

hide…